Skip to main content

Peer Review reports

From: Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease

Original Submission
20 May 2018 Submitted Original manuscript
14 Jul 2018 Author responded Author comments - Anna Schneider
7 Jun 2018 Reviewed Reviewer Report - Amit Assa
24 Jun 2018 Reviewed Reviewer Report - Laura Bauman
Resubmission - Version 2
14 Jul 2018 Submitted Manuscript version 2
19 Jul 2018 Reviewed Reviewer Report - Oren Ledder
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
3 Sep 2018 Editorially accepted
15 Sep 2018 Article published 10.1186/s12876-018-0868-x

You can find further information about peer review here.

Back to article page